Mars Symbioscience

Mars Symbioscience is a research and development (R&D) segment of the Mars company dedicated to improving human health through evidence-based nutritional products. The group emerged in 2005 to focus on developing new findings on the relationship between food, animal health, and human health. It employs more than 130 associates in research centers around the world, including Brazil, the UK, and China. One of the most innovative products Mars Symbioscience has helped create is Cocoavia, a line of cocoa flavanol dietary supplements that promotes better cardiovascular health. The R&D segment has collaborated with researchers at some of the world's leading universities and institutions, including Harvard Medical School and the UC Davis Medical Center, and has published more than 140 peer-reviewed research articles on topics such as cocoa flavanols, prebiotics, and probiotics.

Mars Symbioscience's work is founded on its philosophy that companies like Mars have a responsibility to help improve the health of society. To that end, the R&D segment has set itself the mission of turning science into innovative solutions that people can enjoy as a part of a healthy lifestyle. Mars Symbioscience's approach is multifaceted, with projects encompassing the use of dietary supplements and functional foods to support healthy aging, stress management, and more. Overall, Mars Symbioscience is an illustration of the modern trend in the food and beverage industry towards a more health and wellness-conscious product landscape.